看见一个 Expert Review of Anticancer Therapy。你们前面用依维莫斯,血、肝肾功能还好。下一步是否考虑索拉非尼+依维莫斯。供你参考。
" j5 \4 Y% F* C" {$ C( u. z) _6 b9 _0 h, F
( A1 l! z! F, R# e( b2 q }
Currently available feasibility data for possible combination strategies.
. \8 |1 I, W% G; A( N: P4 a————————————————————————————————
5 i$ ?, o, B( {1 ^2 t* s2 D! }Combination Feasibility according to preliminary data
, \6 ?) W1 i. e( K' j. `2 g2 F6 f& v——————————————————————————————————
2 Z: t) s( z/ y) y' T/ I& s# P. hBevacizumab + sorafenib Yes, reduced dose
7 k; l2 D! E1 V2 M- \: t# |5 uBevacizumab + sunitinib† No * Z3 ?3 L( V3 e ~8 F# \
Bevacizumab + temsirolimus Yes
& U' p9 a- r& C% Y! \4 kBevacizumab + everolimus Yes
+ q8 V% |5 F' P! mSorafenib + sunitinib ? 8 C2 K# m4 f; C8 Y* u3 W' S
Sorafenib + temsirolimus Yes, reduced dose 6 Q* K1 E; [6 r: }6 L! [
Sorafenib + everolimus Yes, reduced dose " Z1 \2 V% ^! v& r' z: m
Sunitinib + temsirolimus† No
) V2 I; o1 g7 Z9 _Sunitinib + everolimus ? ! s! I( @- ~# o4 V/ I1 \
Temsirolimus + everolimus ?
. c4 J" z9 ]$ t! M0 B( h- R/ l4 v————————————————————
L. x* \/ m$ A, `. \" V†Led to US FDA warning.
7 E# t) I% d. r4 h?: As yet unattempted combination.
" q. Q/ j" `3 h1 N2 m8 k |